TAZOPHIN

This brand name is authorized in Nigeria.

Active ingredients

The drug TAZOPHIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM
	Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.
	Read more about Tazobactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4239	Injection	TAZOPHIN INJECTION INJ 1g; 125mg 1VIAL + 10ML SWFI	85 CMS-PP-334263 TAZOPHIN INJECTION CEFTRIAXONE SODIUM + TAZOBACTAM SODIUM Ceftriaxone 1g + Tazobactam 125mg, Sterilized Water For Injection 10ml B4-4239 Drugs Imported Products 1VIAL + 10ML SWFI Prescription Only Medicine (POM) 8/3/2023 GRACE DRUGS & HEALTHCARE LIMITED, OGUNLANA DRIVE, SURULERE LAGOS 8104638301 grace_drugs@hotmail.com Agron Remedies Pvt. Ltd. , Sarverkhera, Moradabad Road, Kashipur, U.S Nagar, Uttarakhand, India, India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD63		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD63

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4239